Maurer-Gebhard, M <br/><br/>
A novel animal model for the evaluation of the efficacy of drugs directed against the ErbB2 receptor on metastasis formation.  [electronic resource] 

 -  Hybridoma  Feb 1999 
 - 69-75 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0272-457X 
<br/><br/><label>Standard No.: </label>10.1089/hyb.1999.18.69  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Carcinoma, Renal Cell--immunology<br/>Disease Models, Animal<br/>ErbB Receptors--immunology<br/>Evaluation Studies as Topic<br/>Humans<br/>Immunocompetence<br/>Immunohistochemistry<br/>Immunotoxins--therapeutic use<br/>Kidney Neoplasms--immunology<br/>Lac Operon<br/>Lung--pathology<br/>Lung Neoplasms--immunology<br/>Mice<br/>Mice, Inbred BALB C<br/>Neoplasm Metastasis--prevention & control<br/>Neoplasm Transplantation<br/>Receptor, ErbB-2--antagonists & inhibitors<br/>Transfection<br/>Tumor Cells, Cultured